These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 20598943)

  • 41. Changing epidemiology of rare mould infections: implications for therapy.
    Malani AN; Kauffman CA
    Drugs; 2007; 67(13):1803-12. PubMed ID: 17722951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options.
    Dodds Ashley E; Drew R; Johnson M; Danna R; Dabrowski D; Walker V; Prasad M; Alexander B; Papadopoulos G; Perfect J
    Pharmacotherapy; 2012 Oct; 32(10):890-901. PubMed ID: 23033228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections.
    Lewis RE
    Am J Ther; 2012 Jan; 19(1):51-63. PubMed ID: 21248618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of voriconazole in the treatment of emerging mycoses].
    Pastor FJ; Guarro J
    Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive fungal infections in renal transplant recipients.
    Badiee P; Alborzi A
    Exp Clin Transplant; 2011 Dec; 9(6):355-62. PubMed ID: 22142041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invasive fungal infections in the ICU.
    Shoham S; Marwaha S
    J Intensive Care Med; 2010; 25(2):78-92. PubMed ID: 19955115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal combination therapy: clinical potential.
    Baddley JW; Pappas PG
    Drugs; 2005; 65(11):1461-80. PubMed ID: 16033288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
    Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The challenge of invasive fungal infection.
    de Pauw BE; Meunier F
    Chemotherapy; 1999 Jun; 45 Suppl 1():1-14. PubMed ID: 10394016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fungal infections.
    Kauffman CA
    Proc Am Thorac Soc; 2006; 3(1):35-40. PubMed ID: 16493149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.
    Azie N; Neofytos D; Pfaller M; Meier-Kriesche HU; Quan SP; Horn D
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):293-300. PubMed ID: 22789847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invasive mycoses: diagnostic challenges.
    Ostrosky-Zeichner L
    Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi.
    Guarro J
    J Antimicrob Chemother; 2011 Jul; 66(7):1447-66. PubMed ID: 21493649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antifungal clinical trials and guidelines: what we know and do not know.
    Pappas PG
    Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a019745. PubMed ID: 25368017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How to select an antifungal agent in critically ill patients.
    Dimopoulos G; Antonopoulou A; Armaganidis A; Vincent JL
    J Crit Care; 2013 Oct; 28(5):717-27. PubMed ID: 24018296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fungal infection in solid organ recipients.
    Fortún J; Ruiz I; Martín-Dávila P; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():49-56. PubMed ID: 22542035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New antifungal antibiotics.
    Paiva JA; Pereira JM
    Curr Opin Infect Dis; 2013 Apr; 26(2):168-74. PubMed ID: 23411420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
    Hou Z; Tan D; Liu G; Xie Y; Li C; Xie J; Lu M; Liu Z; Sha X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):537-42. PubMed ID: 20622324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The changing face of epidemiology of invasive fungal disease in Europe.
    Lass-Flörl C
    Mycoses; 2009 May; 52(3):197-205. PubMed ID: 19391253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.